Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2023

Open Access 01.12.2023 | Research

Spatial distribution and determinants of tetanus toxoid immunization among pregnant women in Ethiopia using data from Ethiopian demographic and health survey 2016

verfasst von: Beletech Fentie, Tewodros Getaneh Alemu, Masresha Asmare Techane, Chalachew Adugna Wubneh, Nega Tezera Assimamaw, Getaneh Mulualem Belay, Tadesse Tarik Tamir, Addis Bilal Muhye, Destaye Guadie Kassie, Amare Wondim, Bewuketu Terefe, Bethelihem Tigabu Tarekegn, Mohammed Seid Ali, Almaz Tefera Gonete, Berhan Tekeba, Selam Fisiha Kassa, Bogale Kassahun Desta, Amare Demsie Ayele, Melkamu Tilahun Dessie, Kendalem Asmare Atalell

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2023

Abstract

Introduction

Tetanus is a major public health problem caused by clostridium tetani. Although it is vaccine-preventable, the case fatality rate among neonates in areas with poor immunization coverage and limited access to clean deliveries reaches 80-100%. Vaccination of pregnant mothers with the tetanus toxoid (TT) vaccine is the most effective way to protect against neonatal tetanus. This study aimed to examine the spatial distribution and determinants of tetanus toxoid immunization among pregnant mothers using the 2016 EDHS data.

Method

Secondary analysis of the Ethiopia Demographic and Health Survey 2016 was done to assess the spatial distribution and determinants of tetanus toxoid vaccine among pregnant women in Ethiopia. Spatial autocorrelation analysis and hot spot analysis were used to detect spatial dependency and spatial clustering of the tetanus toxoid vaccine in Ethiopia. Spatial interpolation was used to predict the tetanus toxoid vaccine coverage in unsampled areas. The multilevel binary logistic regression model was fitted to identify factors associated with tetanus toxoid vaccination. An adjusted odds ratio with 95% CI was calculated and used as the measure of association and a p-value less than 0.05 were considered statistically significant.

Result

From the total of 7043 pregnant women, 42.4% of them have taken at least two doses of tetanus toxoid immunization. Spatial clustering of TT immunization was observed in the Northern, Southwestern and Southwestern parts of Ethiopia. Whereas, low TT coverage was observed in the Eastern and Western parts of the country. Increased ANC visits and the richest economic status favored TT immunization, whereas living in Addis Ababa and Dire Dewa cities decreased the TT immunization coverage.

Conclusion

The finding of this study reveals that TT immunization had spatial dependency, with the highest immunization coverage observed in the Northern, Southwestern and Southeastern parts of the Country. Thus, geographically targeted interventions should be implemented particularly in the eastern and western parts of the country.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
ANC
Ante Natal Care
AOR
Adjusted Odds Ratios
EAs
Enumeration Areas
CSA
Central Statistical Agency
EDHS
Ethiopian Demographic Health Survey
KDHS
Kenian Demographic Health Survey
TTCV
Tetanus Toxoid Containing Vaccine
TT
Tetanus Toxoid

Introduction

Tetanus is a vaccine-preventable disease caused by clostridium tetani. Vaccination of pregnant mothers with the Tetanus toxoid (TT) vaccine is one of the most effective ways to protect against neonatal tetanus disease [1, 2].
Maternal and neonatal tetanus (MNT) remains a major public health problem,with 80-100% case-fatality rate among neonates, especially in areas with poor immunization coverage and limited access to clean deliveries [3, 4]. Globally, an estimated 3.3 million neonatal death occur each year and about 9,000 babies died during the neonatal period every day. From this death, neonatal tetanus shares a high number (34,019 neonatal death) as WHO estimated in 2015 [5, 6].
One of the elimination strategies of neonatal tetanus is achieving ≥ 80% coverage with ≥ 2 doses of tetanus toxoid-containing vaccine (TTCV) among women of reproductive age through routine immunization of pregnant women and supplementary immunization activities [2, 7].
In many parts of low-income countries, however, the efforts made to improve maternal and neonatal protection through TT immunization programs with valid doses of TT (two and more) immunization coverage remains low [1, 3, 8].
In addition, a systemic review conducted in different countries attained at least 80% coverage for women of reproductive age receiving at least two doses of tetanus toxoid-containing vaccine or protection at birth [9].Barriers to maternal and neonatal tetanus elimination were mostly related to health systems and socioeconomic factors [5, 10].
In Ethiopia, the prevalence of tetanus toxoid injection is different in different regions [11]. The variation in the prevalence of TT immunization in pregnant mothers could provide a clue to identify high-risk areas by using spatial methods [11].
Different studies conducted on TT immunization revealed that socioeconomic, and health-related factors were associated with TT immunization [1215]. Even though studies were conducted to identify individual and community-level factors, there was limited evidence on the spatial distribution of TT immunization among pregnant mothers in Ethiopia.
Therefore, this study aimed to determine the high-risk area (hotspot) of TT immunization among pregnant mothers through spatial analysis and identifying factors associated with it.

Methods

Study setting

This study was conducted in Ethiopia using the Ethiopian Demographic and Health Survey (EDHS) 2016. The 2016 EDHS is the fourth national representative cross-sectional survey, which is conducted by the Ethiopian Central Statistical Agency (CSA). The Ethiopian Public Health Institute (EPHI) surveyed in collaboration with the (CSA). The survey was conducted based on a nationally representative sample that provided estimates at the national and regional levels and for urban and rural areas as well.
Ethiopian 2016 demographic and health survey includes nine regions and two administrative cities in Ethiopia. It used sampling frame and multistage sampling technique. This survey includes a total of 645 selected enumeration areas. The survey collects data on the characteristics of the household and lists all household members including TT immunization of pregnant mothers. The target population is all pregnant women in Ethiopia.

Study population

The study population was pregnant mothers in the randomly selected enumeration areas (EAs) of Ethiopia.

Data source

Secondary data analysis from the 2016 Ethiopian demographic health survey was employed to identify the spatial distribution of TT immunization among pregnant mothers. An authorization letter for the use of this data was obtained from measure DHS and the data set was downloaded from the website; www.​measuredhs.​com. The survey covered all nine regions and two administrative cities in Ethiopia.

Sample size determination and sampling procedure

A two-stage stratified cluster sampling was employed to select study participants. From 645 enumeration areas, 15,683 reproductive-age women were included in the survey. About 7193 women were pregnant at the time of the survey or gave birth five years preceding the survey. But 150 women who did not remember TT immunization were excluded from the survey. Therefore the current study includes 7043 pregnant women who gave birth in five years preceding the survey (Fig. 1).

Variables

Dependent variables

The main outcome variable of this study was TT immunization. Data about TT immunization were collected from mothers who were pregnant within 5 years before the survey either by accessing TT immunization through record review or by the mother’s report. Pregnant mothers who took 2 or more doses of the tetanus toxoid vaccine were classified as “protected ” and those who took less than two doses were classified as “ non-protected ” in the current study [1].
Mothers without a record of TT immunization were excluded from the study.

Independent variables

From the 2016 EDHS dataset maternal educational status(no education,primery,secondery and higher), ANC visit(no visit,< 3visit and ≥ 3 visits, residence(urban,rural), wealth index(poorest,poor,middle,richer and richest) and region were considered independent variables.

Data management and analysis

Individual (women’s) record was used from the 2016 EDHS. For the spatial analysis, data management was done by using STATA version 14 software and Microsoft Excel 2007. Mapping was done using ArcGIS version 10.8.
A multilevel logistic regression model was the best-fitted model for the data after LR and ICC tests were checked. In this study, deviance was used for model comparison and the final model was the best-fitted model with the lowest deviance value. The ICC value was 0.258 in the null model, which indicates that about 25.8%% of the overall variability of TT immunization coverage was due to cluster variability. A two-level logistic regression model was fitted to identify factors associated with TT immunization coverage of pregnant mothers in Ethiopia. ANC visits, region and individual wealth index were statistically significant in the multivariable multilevel logistic regression.

Spatial autocorrelations

Spatial autocorrelation (Global Moran’s I) was done to test for spatial clustering of tetanus toxoid immunization among pregnant mothers in Ethiopia. Moran’s I statistics is used to measure whether TT coverage in Ethiopia was distributed randomly, clustered, or dispersed, by taking the entire dataset and producing a single output value, which ranges from − 1 to 1. Moran’s I value close to -1 indicates TT immunization is dispersed in the area. On the other hand, Moran’s I value closer to 1 indicates TT immunization coverage is clustered in the area. Whereas 0 Moran’s I value means the data is randomly distributed. A statistically significant Moran’s I(p < 0.05) leads to the rejection of the null hypothesis (TT immunization is randomly distributed) and accepting the alternative hypothesis that indicates there is spatial dependence of TT immunization in Ethiopia.

Hotspot analysis of TT immunization coverage

Hotspot analysis (Getis-Ord Gi*) was used to identify the spatial clustering of TT immunization in Ethiopia.

Spatial interpolation

Spatial Kriging interpolation was used to estimate the distribution of TT immunization across the region.
Permission was obtained from measure demographic and health survey through an online request at http//www.​dhsprogram.​com and the information obtained was not disclosed to the third party.
All methods were performed following the relevant guidelines and regulations.

Result

Socio-demographic characteristics of the study population

In this study, 7043 pregnant mothers were involved. The majority (32.58%) of the study participants were Orthodox Tewahido religion followers whereas the least were traditional religion followers. Related to residency, three-fourths (79.24%) were rural dwellers. The highest number of participants were from the Oromia regional state(14.15%) and most (60.72%) were illiterate. Regarding maternal age, 28% were in the age groups of 25–29 years and 35.9% of mothers had ≥ 4 antenatal visits (Table 1).
Table 1
Socio demographic characteristics of study population in Ethiopia, EDHS 2019
Variables
Category
Frequency
Percent
Religion
Orthodox
2,295
32.58%
Catholic
48
0.68%
Protestant
1,320
18.74%
Muslim
3,269
46.4%
Traditional
63
0.89%
Others
48
8.68%
Residence
Urban
1,462
20.75%
Rural
5,581
79.24%
Region
Tigray
750
10.64%
Afar
641
9.1%
Amhara
741
10.52%
Oromia
997
14.15%
Somali
799
11.34%
Benshangul
568
8.06%
SNNPR
884
12.55%
Gambela
526
7.46%
Harari
406
5.76%
Addis Ababa
363
5.15%
Dire dawa
368
5.22%
Maternal Education
No education
4,277
60.72%
Incomplete primary
1,729
24.54%
Complete primary
170
2.41%
Incomplete secondary
487
6.91%
Complete secondary
78
1.1%
Higher
302
4.28%
Maternal Age
15–19
354
5.02%
20–24
1,473
20.9%
25–29
1,973
28%
30–34
1,489
21.1%
35–39
1,116
15.8%
40–44
472
6.7%
45–49
166
2.35%
ANC Visits
No visits
2,454
34.8%
< 3visits
2,058
29.22%
≥ 3 visit
2,531
35.9%
Community level Literacy
Low
6,951
44.75%
High
8,582
55.25%
Community level poverty
Low
7,821
50.35%
High
7,712
49.65%

Tetanus toxoid vaccine immunization status

Pregnant mothers who took a minimum of two doses of the tetanus toxoid vaccine were categorized as protected [16]. In the current study, about 42.4% of pregnant mothers have taken a minimum of two doses of the tetanus toxoid vaccine i.e. protected (Fig. 2). When it is seen in the regions of the country, the highest (65.76%) protected mothers were found in the Harari region whereas the minimum (23.56%) were found in the afar regional state of Ethiopia (Table 2).
Table 2
Tetanus vaccine coverage based on the regional states of Ethiopia
Region
Not protected
Protected
N (%)
N (%)
Tigray
452(60.27)
298(39.73)
Afar
490(76.44)
151(23.56)
Amhara
476(64.24)
265(35.76)
Oromia
580(58.17)
417(41.83)
Somali
545(68.21)
254(31.79)
Benishangul
318(55.99)
250(44.01)
SNNPR
489(55.32)
395(44.68)
Gambela
298(56.65)
228(43.35)
Harari
139(34.24)
267(65.76)
Addis Ababa
134(36.91)
229(63.09)
Dire Dewa
132(35.87)
236(64.13)

Spatial analysis of tetanus toxoid immunization

Spatial autocorrelation

The autocorrelation analysis of EDHS 2016 showed that the spatial distribution of tetanus toxoid immunization was significantly varied across Ethiopia, with a Global Moran’s I value of 0.242 (p-value < 0.0001) and a z-score of 15.16. This indicates TT immunization coverage in Ethiopia has spatial dependence (Fig. 3).

Hotspot analysis of TT immunization in Ethiopia

In the mapping of TT immunization, significant spatial clusters were observed in the Northern, western and central parts of Ethiopia. TT immunization spatial dispersion was observed in the Northern, northeastern, and western parts of the country (Fig. 4).

Interpolation of TT immunization

Kriging interpolation was used to map the predicted TT immunization coverage in the observed areas. The highest TT immunization coverage was observed in the Tigray, Amhara, Addis Ababa and Oromia. But, low TT vaccine coverage was observed in the Afar, Somali and Gambela (Fig. 5).

Determinants of Tetanus toxoid vaccine immunization in Ethiopia

A multilevel logistic regression model was the best-fitted model for the data after LR and ICC tests were checked. In this study, deviance was used for model comparison and the final model was the best-fitted model with the lowest deviance value. The ICC value was 0.258 in the null model, which indicates that about 25.8%% of the overall variability of TT immunization coverage was due to cluster variability.
Moreover, the PCV valve in the fnal model indicates the variation in the TT immunization coverage among study participants was clarified by both the individual and community level factors. Model ftness was done using loglikelihood and deviance test, then the final model (Model IV) has the highest loglikelihood and the lowest deviance and was taken as the best-ftted model.
Therefore number of ANC visits, region and individual wealth index were statistically significant in the multivariable multilevel logistic regression. The odds of protective TT immunization among pregnant mothers with no ANC visit and less than 3 visits were 48% [AOR = 0.52, 95%CI (0.43, 0.64)] and 41% [AOR = 0.59,95%CI(0.51, 0.68)] respectively compared to those with ANC visit of ≥ 3. Only 35% of mothers with the poorest income status took a protective dose of TT vaccine [AOR = 0.65, 95%CI (0.50, 0.86)] as compared to those with the richest income level. Based on the regions of the participants, 37% [AOR = 0.63, 95% CI (0.43, 0.81)] and 59% [AOR = 0.41, 95%(0.32, 0.65)] reside in Addis Ababa and Dire Dewa respectively took protective TT immunization (Table 3).
Table 3
Multilevel logistic regression analysis of both individual and community-level factors associated with TT immunization among pregnant mothers in Ethiopia
Individual and community-level characteristics
Model II AOR (95%CI)
Model III AOR (95%CI)
Model IV AOR (95%CI)
Place of residence
Urban
 
1
1
Rural
 
0.55(0.42,0.72)
1.12(0.84,1.49)
ANC visits
no visits
0.59 (0.04, 0.07)
 
0.52(0.43,0.64)
< 3visits
0.62(0.54,0 0.71)
 
0.59(0.51,0.68)
≥ 3 visits
1
 
1
Maternal age
15–19
0.97(0.73,1.29)
 
0.95(0.71,1.26)
20–24
0.98(0.82,1.17)
 
0.99(0.84,1.78)
25–29
1
 
1
30–34
1.08(0.92,1.29)
 
1.08(0.91,1.27)
35–39
0.89(0.74,1.07)
 
0.91(0.75,1.09)
40–44
0.85(0.65,1.12)
 
0.89(0.69,1.17)
45–49
1.05(0.68,1.60)
 
1.09(0.72,1.66)
Maternal educational status
no education
0.79(0.58,1.09)
 
0.52 (0.35,1,02)
primary
0.95(0.71,1.30)
 
0.96 (0.71,1.30)
Secondary
0.87(0.63,1.22)
 
0.89 (0.64,1.23)
higher
1
 
1
Wealth index
Poorest
0.59 (0.48, 0.73)
 
0.65(0.50,0.86)
Poor
0.82(0.65, 1.02)
 
0.87(0.66,1.15)
Middle
0.79(0.63,0.98)
 
0.83(0.63,1.09)
Richer
1.04(0.83,1.30)
 
1.07(0.81,1.41)
Richest
1
 
1
Region
Tigray
 
1
1
Afar
 
0.56(0.37,0.85)
1.83(0.68, 4.94)
Amhara
 
1.12(0.78,1.62)
1.58(0.61, 4.14)
Oromia
 
1.38(0.97,1.96)
1.73(0.70 4.28)
Somali
 
0.86(0.59,1.26)
2.78(1.05, 7.36)
Benshangul
 
1.45(0.98,2.14)
2.17(0.86, 5.51)
SNNPR
 
0.86(0.59,1.26)
0.91(0.33, 2.48)
Gambela
 
1.07(0.72,1.58)
1.76(0.66, 4.71)
Harari
 
3.19(2.06,4.94)
1.60(0.57, 4.46)
Addis Ababa
 
1.29(0.82,2.01)
0.63(0.43, 0.81)
Dire Dewa
 
2.29(1.47,3.56)
0.41(0.32, 0.65)
Community income level
Low
 
0.59(0.53,0.68)
0.81(0.59,1.11
High
 
1
1
Community literacy level
Low
 
0.75(0.59,0.95)
0.94(0.76,1.14)
High
 
1
1
ICC
12.8%
16.1%
7.9%
Log likelihood
-3717.269
-4333.5278
-3657.1076
Deviance
7434.538
8667.055
7314.2152

Discussion

The overall TT vaccination coverage among pregnant women in Ethiopia was 42.4% which is lower than the study conducted at the University of Gondar Comprehensive Specialized Hospital, Ethiopia 69.8% [17], in Southern Ethiopia 51.8 [13], 72.5% [14], India 68% [2], Sudan 60% [18] and Sera Leon 82.12% [19]. The finding from this study is also far below the WHO recommendation, which states 80% immunization coverage to achieve neonatal tetanus elimination [7]. The lower immunization coverage in our study might be because this study is country-wide, which includes the very remote areas, where immunization services were low. On the other hand, the previous studies were conducted mainly in urban, where the immunizations services were relatively good [12, 20].
However, the current finding is higher than the study conducted in Turkey 27.8% [6]. The possible reason could be the sociocultural and economic differences between the two countries. This study is also lower than the study conducted in Dukem town Ethiopia. The higher immunization coverage in our study over the Dukem study could be because of the population difference. The Dukem study was conducted among all reproductive-age women, which might be linked with awareness. Pregnant women had ANC follow-ups, which might have a chance to have advice about the importance of TT immunization for them and their children.
In our study ANC follow-up, geographic region and individual level wealth status were statistically significant in the multivariable multilevel logistic regression model.
In agreement with previous studies conducted in Ethiopia, Sudan, Cameroon, Egypt and five African countries pregnant mothers who have ANC follow-up had 3 times more likely to be immunized for TT [6, 11, 2123] as compared with pregnant mothers who had no ANC follow-up.
The poorest income level of the participants negatively affected TT vaccination in the current study as compared to the richest. This finding is in agreement with the studies conducted in different regions of the world [3, 24]. This finding also in line with the studies conducted in ten east African countries, Sudan and EDHS in five African countries that showed women who has high wealth index took protective dose of TT [18, 25, 26]. This could be due to economic constraints for transportation to health facilities and delay for ANC visits.
Regionally, participants who live in Addis Ababa and Dire Dewa didn’t get adequate TT immunization as compared to those live in Tigray. We expect dwellers of Addis Ababa would get adequate TT immunization as most health facilities are concentrated to this area, but it is not true in the current research finding.

Strength and limitation of the study

The strength of the current study was based on EDHS national data, which is more representative for the total population in the nation and the model of data analysis was spatial and multilevel analysis. As a limitation, the data was only from EDHS 2016 data which doesn’t indicate the trend of TT immunization. In addition, the cross-sectional design of the 2016 EDHS data limits the ability to establish a causal relationship between the studied exposures and tetanus toxoid immunization.

Conclusion

The finding of this study reveals that TT immunization had spatial dependency. Therefore policy makers could give attention for eastern and western part of the country which has low TT immunization. Additionally, lower ANC visit, poorest income level and living in Addis Ababa and Dire Dewa decreased the utilization of protective dose of TT immunization among pregnant mothers. Therefore, the health administrators of these two cities shall create awareness of mothers towards TT immunization using different mechanisms of communication like mass medias.

Acknowledgements

The authors would like to thank measure DHS for their permission to access the data set.

Declarations

Permission was obtained from measure demographic and health survey through online request at http//www.​dhsprogram.​com and the information obtained was not disclosed to the third party. All methods were performed in accordance with the relevant guidelines and regulations.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Dietz V, et al. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ. 1996;74(6):619.PubMedPubMedCentral Dietz V, et al. Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus. Bull World Health Organ. 1996;74(6):619.PubMedPubMedCentral
3.
Zurück zum Zitat Vandelaer J, et al. Tetanus in developing countries: an update on the maternal and neonatal Tetanus Elimination Initiative. Vaccine. 2003;21(24):3442–5.CrossRefPubMed Vandelaer J, et al. Tetanus in developing countries: an update on the maternal and neonatal Tetanus Elimination Initiative. Vaccine. 2003;21(24):3442–5.CrossRefPubMed
4.
Zurück zum Zitat Kalaça S, Yalçın M, Yavuz S. Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity. Public Health. 2004;118(5):377–82.CrossRefPubMed Kalaça S, Yalçın M, Yavuz S. Missed opportunities for tetanus vaccination in pregnant women, and factors associated with seropositivity. Public Health. 2004;118(5):377–82.CrossRefPubMed
5.
Zurück zum Zitat Yusuf N, et al. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries: a systematic review. The Lancet Global Health. 2021;9(11):e1610–7.CrossRefPubMedPubMedCentral Yusuf N, et al. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries: a systematic review. The Lancet Global Health. 2021;9(11):e1610–7.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Maral I, et al. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. Public Health. 2001;115(5):359–64.PubMed Maral I, et al. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage. Public Health. 2001;115(5):359–64.PubMed
7.
Zurück zum Zitat Njuguna HN, et al. Progress toward maternal and neonatal tetanus elimination—worldwide, 2000–2018. Morb Mortal Wkly Rep. 2020;69(17):515.CrossRef Njuguna HN, et al. Progress toward maternal and neonatal tetanus elimination—worldwide, 2000–2018. Morb Mortal Wkly Rep. 2020;69(17):515.CrossRef
8.
Zurück zum Zitat Duclos P, et al. Global immunization: status, progress, challenges and future. BMC Int health Hum rights. 2009;9(1):1–11. Duclos P, et al. Global immunization: status, progress, challenges and future. BMC Int health Hum rights. 2009;9(1):1–11.
9.
Zurück zum Zitat Yusuf N, et al. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries. The Lancet Global Health. 2021;9(11):e1610–7.CrossRefPubMedPubMedCentral Yusuf N, et al. Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries. The Lancet Global Health. 2021;9(11):e1610–7.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Tikmani SS et al. Trends of antenatal care during pregnancy in low-and middle-income countries: findings from the global network maternal and newborn health registry. Seminars in perinatology. 2019. Elsevier. Tikmani SS et al. Trends of antenatal care during pregnancy in low-and middle-income countries: findings from the global network maternal and newborn health registry. Seminars in perinatology. 2019. Elsevier.
11.
Zurück zum Zitat Yaya S, et al. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast. BMC Public Health. 2019;19(1):1–12.CrossRef Yaya S, et al. Antenatal visits are positively associated with uptake of tetanus toxoid and intermittent preventive treatment in pregnancy in Ivory Coast. BMC Public Health. 2019;19(1):1–12.CrossRef
12.
Zurück zum Zitat Haile ZT, Chertok IRA, Teweldeberhan AK. Determinants of utilization of sufficient tetanus toxoid immunization during pregnancy: evidence from the Kenya demographic and health survey, 2008–2009. J Community Health. 2013;38(3):492–9.CrossRefPubMed Haile ZT, Chertok IRA, Teweldeberhan AK. Determinants of utilization of sufficient tetanus toxoid immunization during pregnancy: evidence from the Kenya demographic and health survey, 2008–2009. J Community Health. 2013;38(3):492–9.CrossRefPubMed
13.
Zurück zum Zitat Gebremedhin TS et al. Tetanus toxoid vaccination uptake and associated factors among mothers who gave birth in the last 12 months in Errer District, Somali Regional State, Eastern Ethiopia BioMed Research International, 2020. 2020. Gebremedhin TS et al. Tetanus toxoid vaccination uptake and associated factors among mothers who gave birth in the last 12 months in Errer District, Somali Regional State, Eastern Ethiopia BioMed Research International, 2020. 2020.
14.
Zurück zum Zitat Dubale Mamoro M, Kelbiso L, Hanfore. Tetanus toxoid immunization status and associated factors among mothers in Damboya Woreda, Kembata Tembaro zone, SNNP, Ethiopia Journal of nutrition and metabolism, 2018. 2018. Dubale Mamoro M, Kelbiso L, Hanfore. Tetanus toxoid immunization status and associated factors among mothers in Damboya Woreda, Kembata Tembaro zone, SNNP, Ethiopia Journal of nutrition and metabolism, 2018. 2018.
15.
Zurück zum Zitat Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int health Hum rights. 2018;18(1):1–10.CrossRef Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int health Hum rights. 2018;18(1):1–10.CrossRef
16.
Zurück zum Zitat Yaya S, et al. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. BMC Public Health. 2020;20(1):855.CrossRefPubMedPubMedCentral Yaya S, et al. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. BMC Public Health. 2020;20(1):855.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Gessesse DN, et al. Coverage and determinants of protective dose tetanus toxoid vaccine among postnatal women delivered at university of Gondar comprehensive specialized hospital, northwest Ethiopia, 2019. Clin Epidemiol Global Health. 2021;12:100814.CrossRef Gessesse DN, et al. Coverage and determinants of protective dose tetanus toxoid vaccine among postnatal women delivered at university of Gondar comprehensive specialized hospital, northwest Ethiopia, 2019. Clin Epidemiol Global Health. 2021;12:100814.CrossRef
18.
Zurück zum Zitat Mohamed SOO, Ahmed EM. Prevalence and determinants of antenatal tetanus vaccination in Sudan: a cross-sectional analysis of the multiple Indicator Cluster Survey. Trop Med Health. 2022;50(1):1–6.CrossRef Mohamed SOO, Ahmed EM. Prevalence and determinants of antenatal tetanus vaccination in Sudan: a cross-sectional analysis of the multiple Indicator Cluster Survey. Trop Med Health. 2022;50(1):1–6.CrossRef
19.
Zurück zum Zitat Yaya S, et al. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. BMC Public Health. 2020;20:1–9.CrossRef Yaya S, et al. Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone. BMC Public Health. 2020;20:1–9.CrossRef
20.
Zurück zum Zitat Mehari K, Wencheko E. Factors affecting maternal health care services utilization in rural Ethiopia: a study based on the 2011 EDHS data. Ethiop J Health Dev. 2013;27(1):16–24. Mehari K, Wencheko E. Factors affecting maternal health care services utilization in rural Ethiopia: a study based on the 2011 EDHS data. Ethiop J Health Dev. 2013;27(1):16–24.
21.
Zurück zum Zitat Ahmed A, El-Berrawy M. Factors affecting maternal tetanus vaccination in Dakahlia Governorate, Egypt. J High Inst Public Health. 2019;49(1):30–5.CrossRef Ahmed A, El-Berrawy M. Factors affecting maternal tetanus vaccination in Dakahlia Governorate, Egypt. J High Inst Public Health. 2019;49(1):30–5.CrossRef
22.
Zurück zum Zitat Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int Health Hum Rights. 2018;18(1):27.CrossRefPubMedPubMedCentral Anatea MD, Mekonnen TH, Dachew BA. Determinants and perceptions of the utilization of tetanus toxoid immunization among reproductive-age women in Dukem Town, Eastern Ethiopia: a community-based cross-sectional study. BMC Int Health Hum Rights. 2018;18(1):27.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Mihret MS, Limenih MA, Gudayu TW. The role of timely initiation of antenatal care on protective dose tetanus toxoid immunization: the case of northern Ethiopia post natal mothers. BMC Pregnancy Childbirth. 2018;18(1):235.CrossRefPubMedPubMedCentral Mihret MS, Limenih MA, Gudayu TW. The role of timely initiation of antenatal care on protective dose tetanus toxoid immunization: the case of northern Ethiopia post natal mothers. BMC Pregnancy Childbirth. 2018;18(1):235.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Edet EE, et al. Factors associated with missed opportunities to immunise with tetanus toxoid at a tertiary health institution in Nigeria. Cent Afr J Med. 1998;44(8):199–202.PubMed Edet EE, et al. Factors associated with missed opportunities to immunise with tetanus toxoid at a tertiary health institution in Nigeria. Cent Afr J Med. 1998;44(8):199–202.PubMed
25.
Zurück zum Zitat Belay AT, et al. Prevalence and risk factors associated with rural women’s protected against tetanus in East Africa: evidence from demographic and health surveys of ten east african countries. PLoS ONE. 2022;17(3):e0265906.CrossRefPubMedPubMedCentral Belay AT, et al. Prevalence and risk factors associated with rural women’s protected against tetanus in East Africa: evidence from demographic and health surveys of ten east african countries. PLoS ONE. 2022;17(3):e0265906.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Yeshaw Y, et al. Factors associated with births protected against neonatal tetanus in Africa: Evidences from demographic and health surveys of five african countries. PLoS ONE. 2021;16(6):e0253126.CrossRefPubMedPubMedCentral Yeshaw Y, et al. Factors associated with births protected against neonatal tetanus in Africa: Evidences from demographic and health surveys of five african countries. PLoS ONE. 2021;16(6):e0253126.CrossRefPubMedPubMedCentral
Metadaten
Titel
Spatial distribution and determinants of tetanus toxoid immunization among pregnant women in Ethiopia using data from Ethiopian demographic and health survey 2016
verfasst von
Beletech Fentie
Tewodros Getaneh Alemu
Masresha Asmare Techane
Chalachew Adugna Wubneh
Nega Tezera Assimamaw
Getaneh Mulualem Belay
Tadesse Tarik Tamir
Addis Bilal Muhye
Destaye Guadie Kassie
Amare Wondim
Bewuketu Terefe
Bethelihem Tigabu Tarekegn
Mohammed Seid Ali
Almaz Tefera Gonete
Berhan Tekeba
Selam Fisiha Kassa
Bogale Kassahun Desta
Amare Demsie Ayele
Melkamu Tilahun Dessie
Kendalem Asmare Atalell
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2023
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-023-05911-z

Weitere Artikel der Ausgabe 1/2023

BMC Pregnancy and Childbirth 1/2023 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.